← All stories
Markets
Hikma Pharmaceuticals (LSE:HIK) Sits Between Generics Demand And Regional Uncertainty — Which Force Wins?
Highlights Demand for generic and injectable medicines underpins the commercial story. The lapse of a regional ceasefire has revived questions about operations and logistics. The group's economics differ fundamentally from patent-driven lar…
Covered by 1 outlet
All coverage · 1 article